共 28 条
[21]
[22]
Predictors of Serious Adverse Events and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis treated with Obeticholic Acid.[J] De Vincentis Antonio;D'Amato Daphne;Cristoferi Laura;Gerussi Alessio;Malinverno Federica;Lleo Ana;Colapietro Francesca;Marra Fabio;Galli Andrea;Fiorini Cecilia;Coco Barbara;Brunetto Maurizia;Niro Grazia Anna;Cotugno Rosa;Saitta Carlo;Cozzolongo Raffaele;Losito Francesco;Giannini Edoardo Giovanni;Labanca Sara;Marzioni Marco;Marconi Giulia;Morgando Anna;Pel
[23]
Notoginsenoside R1 Protects Against High Glucose-Induced Cell Injury Through AMPK/Nrf2 and Downstream HO-1 Signaling[J] Du Fawang;Huang Huiling;Cao Yalin;Ran Yan;Wu Qiang;Chen Baolin Frontiers in Cell and Developmental Biology 2021,
[24]
A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model[J] Feng Sen Ling;Zhang Jing;Jin Hongliu;Zhu Wen Ting;Yuan Zhongwen Medical Science Monitor 2021,
[25]
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.[J] Kowdley Kris V;Luketic Velimir;Chapman Roger;Hirschfield Gideon M;Poupon Raoul;Schramm Christoph;Vincent Catherine;Rust Christian;Parés Albert;Mason Andrew;Marschall Hanns-Ulrich;Shapiro David;Adorini Luciano;Sciacca Cathi;Beecher-Jones Tessa;Böhm Olaf;Pencek Richard;Jones David Hepatology (Baltimore; Md.) 2018,
[26]
Cost-Effectiveness Analysis of Obeticholic Acid For The Treatment of Primary Biliary Cholangitis (PBC) Patients With Inadequate Response or Intolerance To Ursodeoxycholic Acid (UDCA) In France[J] L Baschet;S Bourguignon;A Tison Value in Health 2017,
[27]
Obeticholic Acid: First Global Approval.[J] Markham A;Keam Susan J Drugs 2016,
[28]
Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway[J] Ma X;Zhao Y;Zhu Y;Chen Z;Wang J;Li R;Chen C;Wei S;Li J;Liu B;Wang R;Li Y;Wang L;Xiao X Drug Design; Development and Therapy 2015,

